| Literature DB >> 11843915 |
C Cicek-Saydam1, C Cavusoglu, D Burhanoglu, S Hilmioglu, N Ozkalay, A Bilgic.
Abstract
The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first-line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11843915 DOI： 10.1046/j.1469-0691.2001.00341.x
Source DB: PubMed Journal: Clin Microbiol Infect ISSN： 1198-743X Impact factor: 8.067